Methyl 3-Bromo-2-oxo-2H-pyran-5-carboxylate, 95.0%, 1g

5-Ethynyl-2-deoxyuridine (EdU), min 98%, 500 mg, emballage plastique.

2-Bromo-4-trifluoromethylbenzenethiol, 95.0%, 250mg

2-imino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-3,4,5,6,7,8-hexahydro-2H-1-benzopyran-3-carbonitrile, 97%, 25mg

1-(2-Chloroethyl)azetidine hydrochloride, 95+%, 250mg

Bosutinib, 99%, 1g

2-(4-Boronophenyl)-2-methylpropanenitrile, 97.0%, 250mg

30% Acrylamide / Bis-acrylamide (29:1) [for Electrophoresis]250mL

tert-Butyl ((2S,3S)-1-(4-(benzyloxy)phenyl)-4-chloro-3-hydroxybutan-2-yl)carbamate, 98+%, 1g

tert-Butyl (2-cyanopropan-2-yl)carbamate, 100mg

4-Methoxy-[1,4`]bipiperidinyl, 98.0%, 500mg

3-Iodo-5-methoxy-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

tert-Butyl 4-(pyrimidin-4-yl)piperazine-1-carboxylate, 95.0%, 1g